Credit Suisse Ag Vir Biotechnology, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 100,443 shares of VIR stock, worth $842,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,443

Previous 127,772 21.39%

Holding current value

$842,716

Previous $1.29 Million 20.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$8.6 - $11.9 $235,029 - $325,215	-27,329 Reduced 21.39%	100,443 $1.02 Million
Q4 2023 Feb 08, 2024	SELL	$7.76 - $10.29 $383,506 - $508,542	-49,421 Reduced 27.89%	127,772 $1.29 Million
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $296,364 - $798,303	32,425 Added 22.4%	177,193 $1.66 Million
Q2 2023 Aug 11, 2023	SELL	$23.2 - $27.29 $561,532 - $660,527	-24,204 Reduced 14.32%	144,768 $3.55 Million
Q1 2023 May 10, 2023	BUY	$22.26 - $30.85 $957,936 - $1.33 Million	43,034 Added 34.17%	168,972 $3.93 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $773,250 - $1.09 Million	38,740 Added 44.43%	125,938 $3.19 Million
Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $461,284 - $785,648	25,262 Added 40.79%	87,198 $1.68 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $160,443 - $224,520	8,409 Added 15.71%	61,936 $1.58 Million
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $76,919 - $145,236	-3,630 Reduced 6.35%	53,527 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $180,709 - $315,265	5,835 Added 11.37%	57,157 $2.39 Million
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $239,099 - $373,653	-6,851 Reduced 11.78%	51,322 $2.23 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $1.84 Million - $2.43 Million	47,600 Added 450.2%	58,173 $2.75 Million
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $1.35 Million - $4.26 Million	-51,263 Reduced 82.9%	10,573 $542,000
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $1.58 Million - $2.68 Million	61,836 New	61,836 $1.66 Million
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $164,137 - $311,094	-5,804 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$27.89 - $47.86 $69,892 - $119,937	-2,506 Reduced 30.16%	5,804 $238,000
Q1 2020 May 13, 2020	BUY	$12.04 - $60.2 $100,052 - $500,262	8,310 New	8,310 $285,000

Others Institutions Holding VIR

# of Institutions

232

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.11B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account